Investigational Drug Information for Gliolan
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the development status for investigational drug Gliolan?
Gliolan is an investigational drug.
There have been 16 clinical trials for Gliolan.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Glioblastoma, Brain Neoplasms, and Glioma. The leading clinical trial sponsors are photonamic GmbH & Co. KG, National Cancer Institute (NCI), and Constantinos Hadjipanayis.
Summary for Gliolan
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 438 |
WIPO Patent Applications | 0 |
Japanese Patent Applications | 5,276 |
Clinical Trial Progress | Phase 3 (2010-11-01) |
Vendors | 107 |
Recent Clinical Trials for Gliolan
Title | Sponsor | Phase |
---|---|---|
Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma | Hemerion Therapeutics | Phase 2 |
Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma | Institut National de la Santé Et de la Recherche Médicale, France | Phase 2 |
Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma | University Hospital, Lille | Phase 2 |
Clinical Trial Summary for Gliolan
Top disease conditions for Gliolan
Top clinical trial sponsors for Gliolan
US Patents for Gliolan
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |